{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":8,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":8,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"60af21122bd7","filters":{"venue":"Journal of Bioequivalence & Bioavailability"}},"results":[{"id":"W4235998499","doi":"10.4172/jbb","title":"Journal of Bioequivalence & Bioavailability","year":2018,"lang":"fr","type":"paratext","venue":"Journal of Bioequivalence & Bioavailability","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"Fonds de recherche du Québec – Nature et technologies; Natural Sciences and Engineering Research Council of Canada","keywords":"Bioequivalence; Bioavailability; Pharmacology; Computational biology; Medicine; Computer science; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.03540523483618972,"gpt":0.3246727591486874,"spread":0.2892675243124976,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.01564694,0.002078797,0.005672333,0.002102153,0.0005888934,0.0001870409,0.00429759,0.01858216,0.0274916],"category_scores_gemma":[0.00937288,0.001596274,0.003704771,0.002952568,0.01647548,0.001238413,0.0008914009,0.02229009,0.008433285],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002169296,"about_ca_system_score_gemma":0.006634794,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001192091,"about_ca_topic_score_gemma":0.00004046672,"domain_scores_codex":[0.9806862,0.002115017,0.009904711,0.001679491,0.003110799,0.002503807],"domain_scores_gemma":[0.9711818,0.00165407,0.01289845,0.003396511,0.009018274,0.001850976],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01545171,0.01367427,0.05860082,0.01585353,0.008227607,0.002619435,0.003739414,0.00005424395,0.1173315,0.001218631,0.6845588,0.07867002],"study_design_scores_gemma":[0.005654934,0.01481318,0.007595723,0.01308255,0.006035262,0.01354466,0.001685166,0.00005231898,0.08176668,0.001086601,0.8526397,0.002043257],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7115411,0.191727,0.00334078,0.02683328,0.05611929,0.001642395,0.0007553288,0.00008997342,0.007950862],"genre_scores_gemma":[0.6577451,0.2181799,0.02790158,0.002040333,0.02528137,0.00001672966,0.00008727333,0.0004350969,0.06831263],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1680809,"threshold_uncertainty_score":0.9991954,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2537045987","doi":"10.4172/jbb.1000250","title":"Designing, Development and Formulation of Mouth Disintegrating Telmisartan Tablet with Extended Release Profile Using Response Surface Methodology","year":2015,"lang":"en","type":"article","venue":"Journal of Bioequivalence & Bioavailability","topic":"Drug Solubulity and Delivery Systems","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre for Drug Research and Development","funders":"","keywords":"Telmisartan; Pharmacology; Response surface methodology; Computer science; Biochemical engineering; Medicine; Biomedical engineering; Engineering; Machine learning; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.3508444658438323,"gpt":0.4503953101799497,"spread":0.09955084433611738,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01323016,0.0002555444,0.0006275347,0.0001408633,0.0001865294,0.00002767503,0.00023358,0.0002831274,0.00007124399],"category_scores_gemma":[0.001776097,0.0001923786,0.00008334122,0.0003199586,0.0005066002,0.0004439584,0.00008077678,0.0005758698,0.000004530947],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002716881,"about_ca_system_score_gemma":0.00101127,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007510978,"about_ca_topic_score_gemma":0.00001955105,"domain_scores_codex":[0.9946256,0.003086681,0.001186694,0.0003157633,0.0004070035,0.0003782439],"domain_scores_gemma":[0.9960113,0.001234865,0.001240171,0.0002329558,0.00089389,0.0003867903],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.03164845,0.0009469389,0.1704997,0.0005282272,0.0003779117,0.000116355,0.01887582,0.003340677,0.7555808,0.0001235799,0.0003126692,0.01764891],"study_design_scores_gemma":[0.004307508,0.001943067,0.01779561,0.0003638177,0.0004065666,0.0006634161,0.01271195,0.008604494,0.9489973,0.0003097184,0.003328642,0.0005679033],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9910945,0.001014992,0.006864776,0.0001553197,0.0003465152,0.0003936911,0.00003140264,0.00002050605,0.00007830391],"genre_scores_gemma":[0.898973,0.00001712231,0.1007505,0.00005972776,0.00005727487,0.000002345344,0.000002758734,0.00001394627,0.0001233809],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1934165,"threshold_uncertainty_score":0.7844971,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2117943248","doi":"10.4172/jbb.1000113","title":"Comparative Bioavailability: Two Pramipexole Formulations in Healthy Volunteers after a Single Dose Administration under Fasting Conditions","year":2012,"lang":"en","type":"article","venue":"Journal of Bioequivalence & Bioavailability","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Bioavailability; Pramipexole; Pharmacology; Medicine; Pharmacokinetics; Internal medicine; Parkinson's disease; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.1465024108902202,"gpt":0.4379382427566109,"spread":0.2914358318663907,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002068606,0.0002497833,0.000621591,0.0001898055,0.000180366,0.00004963703,0.0001253083,0.0001163687,0.0005906986],"category_scores_gemma":[0.0008132452,0.0002013321,0.0002180352,0.0006008359,0.0005533289,0.001235125,0.00007196727,0.0006537446,0.00005423058],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006209929,"about_ca_system_score_gemma":0.0003392559,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008520709,"about_ca_topic_score_gemma":0.0002507625,"domain_scores_codex":[0.9970788,0.0003257339,0.001207722,0.0002838225,0.0005202572,0.0005836101],"domain_scores_gemma":[0.9974104,0.0007350462,0.0005865957,0.000292889,0.000491753,0.0004832911],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006848915,0.006881693,0.9553256,0.0004231061,0.0002252139,0.00003428206,0.003195158,0.00005233704,0.02220154,0.000442939,0.0003286264,0.004040591],"study_design_scores_gemma":[0.003874554,0.003404459,0.97082,0.0003319398,0.0004408911,0.0003275175,0.004381894,0.0007922741,0.006468363,0.0005527941,0.008207988,0.000397293],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9885048,0.002204521,0.000413499,0.006773807,0.0003892817,0.0005826257,0.00005687366,0.0000246003,0.001049987],"genre_scores_gemma":[0.9964275,0.0001086817,0.002253328,0.0008014441,0.0003256669,0.00002219579,0.00001014063,0.0000120658,0.00003901201],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01573317,"threshold_uncertainty_score":0.8210085,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2519942097","doi":"","title":"Targeting cancer stem cells: Challenges and opportunities","year":2013,"lang":"en","type":"article","venue":"Journal of Bioequivalence & Bioavailability","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Dasatinib; Imatinib; Stem cell; Progenitor cell; Cancer research; Cancer stem cell; Medicine; Tyrosine kinase; Myeloid leukemia; CD34; Haematopoiesis; Chronic myelogenous leukemia; Tyrosine-kinase inhibitor; Population; Immunology; Cancer; Leukemia; Biology; Internal medicine; Cell biology; Receptor","retraction":null,"screen_n_in":null,"score":{"opus":0.08584506014930933,"gpt":0.295643831768893,"spread":0.2097987716195837,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007553791,0.0002318639,0.0005426594,0.0001180334,0.00006733619,0.00003285139,0.0001505347,0.0001282848,0.0007676958],"category_scores_gemma":[0.00006602544,0.0001666132,0.0001382672,0.00006627365,0.0004761991,0.0004134866,0.00008395268,0.0003137844,0.00003099393],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005665708,"about_ca_system_score_gemma":0.000507871,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001262936,"about_ca_topic_score_gemma":0.000005333897,"domain_scores_codex":[0.9980891,0.0001123556,0.0007241791,0.0002820943,0.0004491726,0.0003430744],"domain_scores_gemma":[0.9982099,0.0001332407,0.0004888157,0.0003082193,0.0004930309,0.0003667912],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.000331331,0.0007470102,0.03946486,0.001990466,0.000478478,0.0002640912,0.003147778,0.000005018715,0.09401731,0.0001712969,0.005229657,0.8541527],"study_design_scores_gemma":[0.02548399,0.01282389,0.4002769,0.007738246,0.003321819,0.003621611,0.06292158,0.00203565,0.3430545,0.002443956,0.1330746,0.003203264],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.924855,0.06856049,0.000008020555,0.005380619,0.0003134154,0.0003342692,0.00001133521,0.00002540272,0.0005114429],"genre_scores_gemma":[0.9221298,0.07592209,0.000767081,0.00020869,0.0002739874,0.00001553437,7.833833e-7,0.00001938108,0.0006626957],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8509494,"threshold_uncertainty_score":0.8405731,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2525897054","doi":"","title":"Some statistical issues on the evaluation of the similarity and interchangeability of biologics","year":2013,"lang":"en","type":"article","venue":"Journal of Bioequivalence & Bioavailability","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Interchangeability; Biosimilar; Bioequivalence; Risk analysis (engineering); Biochemical engineering; Computer science; Pharmacology; Biotechnology; Computational biology; Business; Medicine; Engineering; Pharmacokinetics; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.1081024618092854,"gpt":0.357205385288697,"spread":0.2491029234794116,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.007782497,0.0001615414,0.0004597384,0.00005028911,0.00009085216,0.00001229167,0.0004790429,0.0002554963,0.001157765],"category_scores_gemma":[0.005772903,0.0000704892,0.0001888853,0.0001753665,0.003100129,0.0001084582,0.0001970199,0.0005006655,0.000007793876],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006121876,"about_ca_system_score_gemma":0.0001091682,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008079335,"about_ca_topic_score_gemma":0.000008947777,"domain_scores_codex":[0.9961249,0.002357681,0.000853744,0.0002227281,0.0002305431,0.0002103732],"domain_scores_gemma":[0.9965885,0.00129558,0.0006532079,0.000503041,0.0009242828,0.00003543463],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0007892445,0.002015239,0.1751243,0.0003694203,0.0004958382,7.743084e-7,0.0009436337,0.000003601896,0.6788097,0.01613868,0.009312877,0.1159967],"study_design_scores_gemma":[0.0006692266,0.001703911,0.568595,0.0001516289,0.0003383145,0.00002036715,0.000725996,0.0001320623,0.3660533,0.06033556,0.001112275,0.0001623591],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9866003,0.003343821,0.0000574078,0.008914378,0.0004330447,0.00045647,0.0001065566,0.000003965505,0.00008406245],"genre_scores_gemma":[0.9987293,0.0002839325,0.0006460447,0.0002484744,0.00004074252,0.000004686484,9.225153e-7,0.000003814558,0.00004210131],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3934707,"threshold_uncertainty_score":0.9997553,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2519144724","doi":"","title":"Biosimilars? pricing policies in Canada: A new challenge to provincial governments","year":2013,"lang":"en","type":"article","venue":"Journal of Bioequivalence & Bioavailability","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Biosimilar; Business; Medicine; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.0248928237703576,"gpt":0.2675882434322147,"spread":0.2426954196618571,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009820679,0.0002760289,0.0006366172,0.0001648354,0.00007412785,0.00003312883,0.0006141973,0.0002288864,0.001266835],"category_scores_gemma":[0.0008449968,0.0002041274,0.0001611733,0.0004366184,0.000203683,0.0002478967,0.0002116221,0.0005558307,0.00009034159],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001320859,"about_ca_system_score_gemma":0.001860897,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.3787658,"about_ca_topic_score_gemma":0.3231945,"domain_scores_codex":[0.9973609,0.0002916774,0.001093519,0.0003555916,0.000234121,0.0006641715],"domain_scores_gemma":[0.9985569,0.0002215096,0.0004264602,0.0003599875,0.0002195171,0.0002156943],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0006798102,0.0009765499,0.3600122,0.0001861348,0.0002587394,0.00006014116,0.0011978,0.00000817392,0.3935517,0.0002519957,0.08890194,0.1539148],"study_design_scores_gemma":[0.002524165,0.002161996,0.7289162,0.0004298097,0.0001306118,0.0001381228,0.002276201,0.00001946147,0.2017792,0.001061033,0.05967151,0.0008916745],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9794034,0.001767296,0.0001312333,0.01646841,0.0008918689,0.0005045537,0.00004197222,0.0000114657,0.0007797977],"genre_scores_gemma":[0.9952904,0.0001510496,0.001976677,0.001857345,0.0001261947,0.000005687568,7.22342e-7,0.00001332973,0.0005786227],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.368904,"threshold_uncertainty_score":0.9996461,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2531190671","doi":"","title":"Free radical scavenging activity of the Malaysian Leech Saliva extract, Hirudinaria manillensis","year":2013,"lang":"en","type":"article","venue":"Journal of Bioequivalence & Bioavailability","topic":"Leech Biology and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Leech; Pharmacy; Traditional medicine; Lozenge; Medicine; Chemistry; Family medicine; Geography; Archaeology; World Wide Web","retraction":null,"screen_n_in":null,"score":{"opus":0.01980302655715786,"gpt":0.2683141007804675,"spread":0.2485110742233096,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001169067,0.0002018057,0.0005292909,0.0001013485,0.0001475928,0.0000166316,0.0006022213,0.0002502032,0.000688024],"category_scores_gemma":[0.0008967051,0.0001188163,0.0004379317,0.0003929619,0.001045086,0.0002494873,0.0001876031,0.0007246783,0.00003271769],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001649814,"about_ca_system_score_gemma":0.0002555688,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001100555,"about_ca_topic_score_gemma":0.000006813798,"domain_scores_codex":[0.9980285,0.0002120271,0.0007386805,0.0002733749,0.000431596,0.0003158233],"domain_scores_gemma":[0.9973558,0.0002665972,0.0007049371,0.001023087,0.000441407,0.0002081876],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0002338155,0.0009465319,0.2138397,0.00018672,0.0001413859,0.00001185491,0.000160107,0.000001790199,0.7624573,0.0004359796,0.004670263,0.01691457],"study_design_scores_gemma":[0.0009852152,0.0004526897,0.7377875,0.0002307082,0.0002504883,0.0004793534,0.0001983703,0.0001150134,0.2556018,0.001748329,0.001983403,0.0001670688],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9814572,0.0003049916,0.0002776885,0.0165449,0.0002283896,0.0004680209,0.00002572231,0.00001982976,0.0006732387],"genre_scores_gemma":[0.9961642,0.0001100264,0.003094336,0.0002113129,0.00020886,0.000009537072,9.005204e-7,0.00001241103,0.0001884121],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5239478,"threshold_uncertainty_score":0.753338,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2522289024","doi":"","title":"Regulatory consideration of the assessment of biosimilar products","year":2013,"lang":"en","type":"article","venue":"Journal of Bioequivalence & Bioavailability","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Biosimilar; Harmonization; Scope (computer science); Interchangeability; Risk analysis (engineering); Business; Product (mathematics); Order (exchange); Bioequivalence; Medicine; Biotechnology; Pharmacology; Computer science; Finance; Pharmacokinetics","retraction":null,"screen_n_in":null,"score":{"opus":0.0237267121275939,"gpt":0.2906560368767194,"spread":0.2669293247491255,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002190612,0.0001663002,0.0005346832,0.000090891,0.00007982073,0.0000114787,0.0004409793,0.0002488533,0.0009240104],"category_scores_gemma":[0.001041458,0.00009405659,0.0002859154,0.0003277496,0.001678279,0.0001887304,0.000127014,0.000390498,0.000007396566],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006387621,"about_ca_system_score_gemma":0.0003686006,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002212397,"about_ca_topic_score_gemma":0.000002810528,"domain_scores_codex":[0.9974708,0.000700054,0.001201759,0.0002240027,0.0001765473,0.0002268393],"domain_scores_gemma":[0.9966766,0.0002808219,0.001230654,0.0006111822,0.001164299,0.00003643556],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00003472711,0.0003432764,0.07160776,0.0001409044,0.0001119826,4.157353e-7,0.00005684669,0.000001421288,0.9189083,0.0006110296,0.004927521,0.003255806],"study_design_scores_gemma":[0.0003509698,0.0003820289,0.3018669,0.00009625162,0.00009798387,0.0000327076,0.0001079531,0.000008643961,0.6943923,0.0007985662,0.001779904,0.00008568986],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912695,0.001706157,0.0001463693,0.005081473,0.0009297299,0.0003928946,0.00002963115,0.000006794681,0.0004374169],"genre_scores_gemma":[0.9939315,0.00009823721,0.005506102,0.0001667384,0.0000392888,0.000002417417,7.667832e-7,0.000006462823,0.000248448],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2302592,"threshold_uncertainty_score":0.9999893,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}